175 related articles for article (PubMed ID: 34504783)
1. RanBP3 Regulates Proliferation, Apoptosis and Chemosensitivity of Chronic Myeloid Leukemia Cells
Li Q; Huang Z; Peng Y; Wang X; Jiang G; Wang T; Mou K; Feng W
Front Oncol; 2021; 11():698410. PubMed ID: 34504783
[TBL] [Abstract][Full Text] [Related]
2. RanBP3 Regulates Melanoma Cell Proliferation via Selective Control of Nuclear Export.
Pathria G; Garg B; Wagner C; Garg K; Gschaider M; Jalili A; Wagner SN
J Invest Dermatol; 2016 Jan; 136(1):264-74. PubMed ID: 26763446
[TBL] [Abstract][Full Text] [Related]
3. KPT-330 inhibition of chromosome region maintenance 1 is cytotoxic and sensitizes chronic myeloid leukemia to Imatinib.
Nie D; Huang K; Yin S; Li Y; Xie S; Ma L; Wang X; Wu Y; Xiao J; Wang J; Yang W; Liu H
Cell Death Discov; 2018; 4():48. PubMed ID: 29707241
[TBL] [Abstract][Full Text] [Related]
4. Ran-binding protein 3 links Crm1 to the Ran guanine nucleotide exchange factor.
Nemergut ME; Lindsay ME; Brownawell AM; Macara IG
J Biol Chem; 2002 May; 277(20):17385-8. PubMed ID: 11932251
[TBL] [Abstract][Full Text] [Related]
5. Cysteine-rich protein 61 regulates the chemosensitivity of chronic myeloid leukemia to imatinib mesylate through the nuclear factor kappa B/Bcl-2 pathway.
Song Y; Lin Q; Cai Z; Hao T; Zhang Y; Zhu X
Cancer Sci; 2019 Aug; 110(8):2421-2430. PubMed ID: 31145521
[TBL] [Abstract][Full Text] [Related]
6. RanBP3 enhances nuclear export of active (beta)-catenin independently of CRM1.
Hendriksen J; Fagotto F; van der Velde H; van Schie M; Noordermeer J; Fornerod M
J Cell Biol; 2005 Dec; 171(5):785-97. PubMed ID: 16314428
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the Nrf2-TrxR Axis Sensitizes the Drug-Resistant Chronic Myelogenous Leukemia Cell Line K562/G01 to Imatinib Treatments.
Xu L; Zhao Y; Pan F; Zhu M; Yao L; Liu Y; Feng J; Xiong J; Chen X; Ren F; Tan Y; Wang H
Biomed Res Int; 2019; 2019():6502793. PubMed ID: 31828114
[TBL] [Abstract][Full Text] [Related]
8. EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway.
Huang R; Liu H; Chen Y; He Y; Kang Q; Tu S; He Y; Zhou X; Wang L; Yang J; Wu A; Li Y
Oncol Rep; 2018 Jan; 39(1):119-128. PubMed ID: 29192326
[TBL] [Abstract][Full Text] [Related]
9. RanBP3 influences interactions between CRM1 and its nuclear protein export substrates.
Englmeier L; Fornerod M; Bischoff FR; Petosa C; Mattaj IW; Kutay U
EMBO Rep; 2001 Oct; 2(10):926-32. PubMed ID: 11571268
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-1301-Mediated RanGAP1 Downregulation Induces BCR-ABL Nuclear Entrapment to Enhance Imatinib Efficacy in Chronic Myeloid Leukemia Cells.
Lin TY; Chen KC; Liu HJ; Liu AJ; Wang KL; Shih CM
PLoS One; 2016; 11(5):e0156260. PubMed ID: 27228340
[TBL] [Abstract][Full Text] [Related]
11. A molecular and biophysical comparison of macromolecular changes in imatinib-sensitive and imatinib-resistant K562 cells exposed to ponatinib.
Yandim MK; Ceylan C; Elmas E; Baran Y
Tumour Biol; 2016 Feb; 37(2):2365-78. PubMed ID: 26373734
[TBL] [Abstract][Full Text] [Related]
12. RPS27a promotes proliferation, regulates cell cycle progression and inhibits apoptosis of leukemia cells.
Wang H; Yu J; Zhang L; Xiong Y; Chen S; Xing H; Tian Z; Tang K; Wei H; Rao Q; Wang M; Wang J
Biochem Biophys Res Commun; 2014 Apr; 446(4):1204-10. PubMed ID: 24680683
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of importin-α3 bound to the nuclear localization signal of Ran-binding protein 3.
Koyama M; Matsuura Y
Biochem Biophys Res Commun; 2017 Sep; 491(3):609-613. PubMed ID: 28760339
[TBL] [Abstract][Full Text] [Related]
14. Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells.
Al-Jamal HA; Jusoh SA; Yong AC; Asan JM; Hassan R; Johan MF
Asian Pac J Cancer Prev; 2014; 15(11):4555-61. PubMed ID: 24969884
[TBL] [Abstract][Full Text] [Related]
15. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
[TBL] [Abstract][Full Text] [Related]
16. CUEDC2 sensitizes chronic myeloid leukemic cells to imatinib treatment.
Zhang H; Chang G; Wang J; Lin Y; Ma L; Pang T
Leuk Res; 2013 Nov; 37(11):1583-91. PubMed ID: 24125838
[TBL] [Abstract][Full Text] [Related]
17. Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms.
Lan X; Zhao C; Chen X; Zhang P; Zang D; Wu J; Chen J; Long H; Yang L; Huang H; Carter BZ; Wang X; Shi X; Liu J
J Hematol Oncol; 2016 Nov; 9(1):129. PubMed ID: 27884201
[TBL] [Abstract][Full Text] [Related]
18. [Effect of Stably Down-regulating FMI Expression of K562 Cells on Sensitivity of K562 cells to Imatinib Mesylate].
Han YH; Zhang HX; Hong F; Yu D; Hu CY; Sun Q; Zeng LY; Li ZY; Yan ZL; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):708-716. PubMed ID: 31204920
[TBL] [Abstract][Full Text] [Related]
19. Novel agent nitidine chloride induces erythroid differentiation and apoptosis in CML cells through c-Myc-miRNAs axis.
Liu N; Li P; Zang S; Liu Q; Ma D; Sun X; Ji C
PLoS One; 2015; 10(2):e0116880. PubMed ID: 25647305
[TBL] [Abstract][Full Text] [Related]
20. [Growth inhibition and differentiation of imatinib-resistant chronic myeloid leukemia cell induced by cell differentiation agent in vitro].
Wang XD; Qiu L; Lu RZ; Chen LJ; Zhan ZM; Han BH; Zhang BL; Ma J
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3399-405. PubMed ID: 18476538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
